HC Wainwright Reiterates “Buy” Rating for Sana Biotechnology (NASDAQ:SANA)
HC Wainwright restated their buy rating on shares of Sana Biotechnology (NASDAQ:SANA – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $11.00 target price on the stock. SANA has been the topic of a number of other reports. Citizens Jmp raised shares of Sana Biotechnology […]
